J&J Bets On Robotics, Cardiovascular To Grow Medtech As Tariff Hit Eases, US Manufacturing Grows

Tariff Relief To Be Reinvested In Medtech Pipeline And Domestic Production

 
• By Shubham Singh
  
Johnson & Johnson expects OTTAVA to show strong differentiation both in its robotic and digital capabilities. Picture Courtesy: Shutterstock

More from Strategy

More from Business